HIV-1 Antiretroviral Resistance in Cuba, 2009-2014.

CONCLUSIONS Detected levels of transmitted drug resistance highlight the need for a national surveillance study in treatment-naïve patients. Resistance prevalence is high in previously treated patients but appears to be decreasing over time. The frequency of resistance mutations in recombinant forms of HIV in Cuba needs further study. KEYWORDS Antiretroviral therapy, highly active antiretroviral therapy, HIV, anti-HIV agents, drug resistance, multiple drug resistance, Cuba. PMID: 31242157 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31242157?dopt=Abstract

Source: MEDICC Review - June 28, 2019 Category: International Medicine & Public Health Tags: MEDICC Rev Source Type: research